مباشر
CellA skin-hypothalamus axis couples heat stress and metabolic dysfunctionCellThe evolution of high-order genome architecture revealed from 1,000 speciesCellSomatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative statesCellPyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylationCellMechanism-guided identification of antidepressant G protein-coupled receptor drug targetsBDArea Softball: PRB gets 2 wins - Brainerd DispatchFierceBiotechWCG acquires The Contract Network in bid to streamline clinical trial executionRecursionRecursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com CanadaRecursionRecursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock TitanRecursion[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
Endpoints News ٢٦ نوفمبر ٢٠٢٥

China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna

China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna

المصدر
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.